Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma

ClinicalTrials.gov ID: NCT00079937

Public ClinicalTrials.gov record NCT00079937. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 1 Year, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Evaluation of Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Persistent, Inadequately Controlled Allergic Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A substance called immunoglobulin E (IgE), which is naturally produced by our body, has a key role in generating asthma attacks. In patients with allergies, there is an exaggerated production of IgE in response to specific substances such as pollens. Omalizumab is a new drug that inactivates IgE. This study tested the safety and efficacy of omalizumab against asthma attacks in children with allergic asthma.

Study identification

NCT ID
NCT00079937
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
628 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2004 (Type not available)
Primary completion
Mar 2008 (Actual)
Completion
Mar 2008 (Actual)
Last update posted
Apr 11, 2012

2004 – 2008

United States locations

U.S. sites
56
U.S. states
25
U.S. cities
51
Facility City State ZIP Site status
Alabama Allergy and Asthma Center Birmingham Alabama 35209 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72202 —
Clinical Research Center Little Rock Arkansas 72205 —
Allergy and Asthma Specialists Medical Group Huntington Beach California 92647 —
Pediatric Care and Medical Group Huntington Beach California 92647 —
West Coast Clinical Trials Long Beach California 90806 —
Southern California Research Center Mission Viejo California 92691 —
Children's Hosptial of Orange County, Div Asthma, Allergy & Immunology Orange California 92868 —
CA Allergy & Asthma Med Group Palmdale California 93551 —
Dr. Joann Blessing-Moore Palo Alto California 94304 —
Integrated Research Group Riverside California 92506 —
Allergy Associates Medical Group San Diego California 92120 —
Allergy and Asthma Medical Group & Research Center San Diego California 92123 —
Allergy and Asthma Associates of Santa Clara Valley RC San Jose California 95117 —
1304 15th St Santa Monica California 90404 —
Bensch Research Associates Stockton California 95207 —
Allergy & Asthma Med Group of Diablo Valley CR Walnut Creek California 94598 —
National Jewish Medical and Research Center Denver Colorado 80206 —
Miami Children's Hospital Miami Florida 33155 —
Georgia Pollens Albany Georgia 31707 —
Family Allergy and Asthma Center, PC Atlanta Georgia 30342 —
Aeroallergy Research Labs of Savannah, Inc Savannah Georgia 31406 —
Rush University Medical Center Chicago Illinois 60612 —
Asthma & Allergy Center Elliott Maryland 21042 —
Northeast Med Research Associates North Dartmouth Massachusetts 02747 —
St. Louis University School of Medicine St Louis Missouri 63104 —
Midwest Allergy & Asthma Clinic Omaha Nebraska 68114 —
Ocean Allergy & Respiratory Research Center Brick New Jersey 08724 —
UMDNJ Newark New Jersey 07101 —
Womes And childrens Hospital of Buffalo Buffalo New York 14222 —
Asthma & Allergy Associates Ithaca New York 14850 —
Allergy and Asthma Diagnostic Office Liverpool New York 13088 —
Island Medical Research (Allergy and Asthma Center) Rockville Centre New York 11570 —
Duke University Medical Center Durham North Carolina 27710 —
Allergy & Asthma Center of North carolina High Point North Carolina 27262 —
Bernstein Clinical Research Center Cincinnati Ohio 45231 —
Resp Dis of Children and Adolescents Oklahoma City Oklahoma 73112 —
Clinical Research Institute of Southern Oregon Medford Oregon 97504 —
501 Howard Av Altoona Pennsylvania 16601 —
West Penn Allegheny General Health System Pittsburgh Pennsylvania 15212 —
Asthma and Allergy Associates Upland Pennsylvania 19013 —
AAPRI Clinical Research Institute Lincoln Rhode Island 02865 —
Allergy Assoc., The ASthma, Allergy & Sinus Ctr Knoxville Tennessee 37922 —
Vanderbilt University Nashville Tennessee 37203 —
Pediatric Allergy/Immunology Associates, PA Dallas Texas 75230 —
Pediatric Pulmonary Association of North Texas Dallas Texas 75230 —
North Texas Institute for Clinical Trials Fort Worth Texas 76132 —
Baylor College of Medicine Houston Texas 77030 —
7707 Fannin/Ste. 195 Houston Texas 77054 —
Sylvanna Research San Antonio Texas 78229 —
Copperview Medical Center South Jordan Utah 84095 —
Childrens Hospital of the Kings Daughters Norfolk Virginia 23507 —
Virgina Commonwealth Richmond Virginia 23219 —
A.S.T.H.M.A., Inc. Seattle Washington 98105 —
508 W 6th Av Spokane Washington 99204 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00079937, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 11, 2012 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00079937 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →